AUD 0.29
(-2.36%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 26.88 Million AUD | 6.99% |
2023 | 25.12 Million AUD | 30.97% |
2022 | 19.18 Million AUD | 2.23% |
2021 | 18.76 Million AUD | -0.02% |
2020 | 18.76 Million AUD | -3.36% |
2019 | 19.42 Million AUD | 11.02% |
2018 | 17.49 Million AUD | -0.79% |
2017 | 17.63 Million AUD | 5.47% |
2016 | 16.71 Million AUD | 8.87% |
2015 | 15.35 Million AUD | 4.43% |
2014 | 14.7 Million AUD | 0.11% |
2013 | 14.68 Million AUD | -12.92% |
2012 | 16.86 Million AUD | -4.55% |
2011 | 17.67 Million AUD | 3.07% |
2010 | 17.14 Million AUD | -14.51% |
2009 | 20.05 Million AUD | -1.16% |
2008 | 20.29 Million AUD | 1.88% |
2007 | 19.91 Million AUD | -9.81% |
2006 | 22.08 Million AUD | -8.83% |
2005 | 24.22 Million AUD | 40.01% |
2004 | 17.29 Million AUD | -54.09% |
2003 | 37.67 Million AUD | 163.07% |
2002 | 14.32 Million AUD | 1111.02% |
2001 | 1.18 Million AUD | 1102.24% |
2000 | -118 Thousand AUD | -105.98% |
1999 | 1.97 Million AUD | 1545.0% |
1998 | 120 Thousand AUD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 FY | 26.85 Million AUD | 6.88% |
2024 Q2 | 14.62 Million AUD | 0.0% |
2024 Q4 | 12.23 Million AUD | 0.0% |
2023 Q2 | 18.14 Million AUD | 0.0% |
2023 Q4 | 8.53 Million AUD | 0.0% |
2023 FY | 25.12 Million AUD | 30.97% |
2022 Q4 | 9.74 Million AUD | 0.0% |
2022 Q2 | 9.43 Million AUD | 0.0% |
2022 FY | 19.18 Million AUD | 2.23% |
2021 Q4 | 9.96 Million AUD | 0.0% |
2021 FY | 18.76 Million AUD | -0.02% |
2021 Q2 | 8.8 Million AUD | 0.0% |
2020 Q4 | 9.38 Million AUD | 0.0% |
2020 Q2 | 9.31 Million AUD | 0.0% |
2020 FY | 18.76 Million AUD | -3.36% |
2019 FY | 19.42 Million AUD | 11.02% |
2019 Q4 | 10 Million AUD | 0.0% |
2019 Q2 | 9.56 Million AUD | 0.0% |
2018 FY | 17.49 Million AUD | -0.79% |
2018 Q4 | 8.93 Million AUD | 0.0% |
2018 Q2 | 8.55 Million AUD | 0.0% |
2017 Q4 | 9.31 Million AUD | 0.0% |
2017 FY | 17.63 Million AUD | 5.47% |
2017 Q2 | 8.31 Million AUD | 0.0% |
2016 Q2 | 7.95 Million AUD | 0.0% |
2016 FY | 16.71 Million AUD | 8.87% |
2016 Q4 | 8.76 Million AUD | 0.0% |
2015 Q4 | 7.69 Million AUD | 0.0% |
2015 FY | 15.35 Million AUD | 4.43% |
2015 Q2 | 7.65 Million AUD | 0.0% |
2014 Q2 | 7.2 Million AUD | 0.0% |
2014 FY | 14.7 Million AUD | 0.11% |
2014 Q4 | 7.5 Million AUD | 0.0% |
2013 FY | 14.68 Million AUD | -12.92% |
2013 Q2 | 7.62 Million AUD | 0.0% |
2013 Q4 | 7.06 Million AUD | 0.0% |
2012 FY | 16.86 Million AUD | -4.55% |
2012 Q3 | 3.91 Million AUD | 0.0% |
2012 Q2 | 3.91 Million AUD | -15.01% |
2012 Q1 | 4.61 Million AUD | 0.0% |
2012 Q4 | 3.91 Million AUD | 0.0% |
2011 Q3 | 4.61 Million AUD | 0.0% |
2011 Q4 | 4.61 Million AUD | 0.0% |
2011 FY | 17.67 Million AUD | 3.07% |
2011 Q1 | 4.58 Million AUD | 0.0% |
2011 Q2 | 4.61 Million AUD | 0.52% |
2010 Q2 | 4.58 Million AUD | -1.81% |
2010 Q3 | 4.58 Million AUD | 0.0% |
2010 Q4 | 4.58 Million AUD | 0.0% |
2010 FY | 17.14 Million AUD | -14.51% |
2010 Q1 | 4.67 Million AUD | 0.0% |
2009 FY | 20.05 Million AUD | -1.16% |
2009 Q4 | 4.67 Million AUD | 0.0% |
2009 Q2 | 4.67 Million AUD | -10.96% |
2009 Q1 | 5.24 Million AUD | 0.0% |
2009 Q3 | 4.67 Million AUD | 0.0% |
2008 Q1 | 4.86 Million AUD | 0.0% |
2008 FY | 20.29 Million AUD | 1.88% |
2008 Q4 | 5.24 Million AUD | 0.0% |
2008 Q3 | 5.24 Million AUD | 0.0% |
2008 Q2 | 5.24 Million AUD | 7.92% |
2007 FY | 19.91 Million AUD | -9.81% |
2007 Q4 | 4.86 Million AUD | 0.0% |
2007 Q3 | 4.86 Million AUD | 0.0% |
2007 Q2 | 4.86 Million AUD | -11.92% |
2007 Q1 | 5.52 Million AUD | 0.0% |
2006 Q1 | 5.8 Million AUD | 0.0% |
2006 Q3 | 5.52 Million AUD | 0.0% |
2006 Q4 | 5.52 Million AUD | 0.0% |
2006 FY | 22.08 Million AUD | -8.83% |
2006 Q2 | 5.52 Million AUD | -4.93% |
2005 Q3 | 5.8 Million AUD | 0.0% |
2005 Q2 | 5.8 Million AUD | 38.01% |
2005 Q4 | 5.8 Million AUD | 0.0% |
2005 Q1 | 4.2 Million AUD | 0.0% |
2005 FY | 24.22 Million AUD | 40.01% |
2004 Q3 | 4.2 Million AUD | 0.0% |
2004 Q2 | 4.2 Million AUD | 756.15% |
2004 Q4 | 4.2 Million AUD | 0.0% |
2004 Q1 | 491.41 Thousand AUD | 0.0% |
2004 FY | 17.29 Million AUD | -54.09% |
2003 FY | 37.67 Million AUD | 163.07% |
2003 Q4 | 491.41 Thousand AUD | 0.0% |
2003 Q3 | 491.41 Thousand AUD | 0.0% |
2003 Q2 | 491.41 Thousand AUD | -9.29% |
2003 Q1 | 541.75 Thousand AUD | 0.0% |
2002 Q3 | 541.75 Thousand AUD | 0.0% |
2002 Q4 | 541.75 Thousand AUD | 0.0% |
2002 FY | 14.32 Million AUD | 1111.02% |
2002 Q1 | 88 Thousand AUD | 0.0% |
2002 Q2 | 541.75 Thousand AUD | 515.63% |
2001 Q2 | 88 Thousand AUD | 265.26% |
2001 FY | 1.18 Million AUD | 1102.24% |
2001 Q3 | 88 Thousand AUD | 0.0% |
2001 Q1 | -53.25 Thousand AUD | 0.0% |
2001 Q4 | 88 Thousand AUD | 0.0% |
2000 Q4 | -53.25 Thousand AUD | 0.0% |
2000 Q2 | -53.25 Thousand AUD | -106.68% |
2000 Q3 | -53.25 Thousand AUD | 0.0% |
2000 Q1 | 797.25 Thousand AUD | 0.0% |
2000 FY | -118 Thousand AUD | -105.98% |
1999 Q2 | 797.25 Thousand AUD | 55.49% |
1999 FY | 1.97 Million AUD | 1545.0% |
1999 Q4 | 797.25 Thousand AUD | 0.0% |
1999 Q1 | 512.75 Thousand AUD | 0.0% |
1999 Q3 | 797.25 Thousand AUD | 0.0% |
1998 FY | 120 Thousand AUD | 0.0% |
1998 Q2 | 512.75 Thousand AUD | 0.0% |
1998 Q3 | 512.75 Thousand AUD | 0.0% |
1998 Q4 | 512.75 Thousand AUD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
4DMedical Limited | 31.48 Million AUD | 14.623% |
Adherium Limited | 267.7 Thousand AUD | -9940.978% |
Aroa Biosurgery Limited | 66.09 Million AUD | 59.334% |
Atomo Diagnostics Limited | 1.6 Million AUD | -1573.72% |
Anteris Technologies Ltd | 69.14 Million AUD | 61.128% |
Control Bionics Limited | 9.82 Million AUD | -173.562% |
CardieX Limited | 16.64 Million AUD | -61.451% |
Cochlear Limited | 1.17 Billion AUD | 97.712% |
CleanSpace Holdings Limited | 11.35 Million AUD | -136.634% |
Cyclopharm Limited | 13.38 Million AUD | -100.884% |
EMVision Medical Devices Ltd | 12.83 Million AUD | -109.45% |
Nova Eye Medical Limited | 23.99 Million AUD | -12.047% |
HeraMED Limited | 6.78 Million AUD | -296.287% |
Imricor Medical Systems, Inc. | -1.11 Million AUD | 2508.95% |
ImpediMed Limited | 28.04 Million AUD | 4.14% |
InhaleRx Limited | 2.59 Million AUD | -937.624% |
LBT Innovations Limited | 1.1 Million AUD | -2328.184% |
Micro-X Limited | 18.76 Million AUD | -43.253% |
Neurotech International Limited | 8.75 Million AUD | -207.049% |
OncoSil Medical Limited | 12.03 Million AUD | -123.259% |
PolyNovo Limited | 34.92 Million AUD | 23.028% |
Respiri Limited | 8.03 Million AUD | -234.542% |
SomnoMed Limited | 58.97 Million AUD | 54.419% |
Universal Biosensors, Inc. | 20 Million AUD | -34.398% |
Uscom Limited | 5.52 Million AUD | -386.953% |
Visioneering Technologies, Inc. | 9.63 Million AUD | -179.022% |